RCT: In operated patients with head and neck cancer, chemoradiotherapy with weekly cisplatin is noninferior to 3-weekly cisplatin and is associated with reduced toxicity.

Weekly Cisplatin Plus Radiation for Postoperative Head and Neck Cancer (JCOG1008): A Multicenter, Noninferiority, Phase II/III Randomized Controlled Trial – Journal of Clinical Oncology

Commentary from the author on Twitter

Dear friends,
Finally, the results of JCOG1008, post operative CRT (weekly CDDP vs. 3-weekly CDDP) has published on Journal of Oncology.
Weekly CDDP+RT is a new treatment option with equal efficacy and better safety profile.
Please check the manuscript!!https://t.co/XG6mkGeo4Y

— Naomi Kiyota (@kiyota_naomi) March 1, 2022